StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
FHTX

Foghorn Therapeutics Inc.

FHTX Nasdaq Pharmaceutical Preparations EDGAR ↗
$4.61
-0.13 -2.74%

Key statistics

from XBRL data in SEC filings
Market cap
$271M
Revenue (TTM)
$28.2M
Net income (TTM)
-$75.3M
EPS (TTM)
$-1.17
P/E ratio
Dividend yield
Free cash flow
-$86.1M
Cash
$87.7M
Total assets
$222M
Gross margin
52-week range
$3.27 – $6.95

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 24, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2026 8-K Regulation FD disclosure; Other events Apr 21, 2026 10-K Fiscal year ended 2025-12-31 Mar 11, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 11, 2026 8-K Director or officer change; Other events Feb 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 12, 2026 8-K Director or officer change Dec 4, 2025 8-K Regulation FD disclosure Nov 7, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Nov 5, 2025 8-K Regulation FD disclosure; Other events Oct 30, 2025 8-K Regulation FD disclosure Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 5, 2025 8-K Entered a material agreement; Terminated a material agreement Jul 1, 2025 8-K Shareholder vote results Jun 17, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2025 8-K Director or officer change; Other events May 1, 2025 8-K Regulation FD disclosure; Other events Apr 28, 2025 8-K Regulation FD disclosure Mar 24, 2025 8-K Other events Mar 20, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Regulation FD disclosure Feb 3, 2025 8-K Delisting notice or listing-rule failure Jan 24, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Director or officer change Dec 30, 2024 8-K Regulation FD disclosure; Other events Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2024 8-K Regulation FD disclosure; Other events Oct 10, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 8-K Shareholder vote results Jun 26, 2024 8-K Regulation FD disclosure Jun 3, 2024 8-K Regulation FD disclosure May 23, 2024 8-K Entered a material agreement; Other events May 22, 2024